Efficacy of Fulvestrant in Heavily Pretreated Postmenopausal Women with Advanced Breast Cancer: A Preliminary Report

PURPOSE: Fulvestrant, a potent estrogen receptor (ER) antagonist with a novel mechanism of action, has shown efficacy in pretreated patients with advanced breast cancer. We assessed the efficacy and tolerability of fulvestrant in Korean postmenopausal women. METHODS: Of the 25 candidates identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Changhoon, Kim, Sung-Bae, Ahn, Jin-Hee, Jung, Kyung Hae, Ahn, Yongchel, Gong, Gyungyub, Kim, Hak-Hee, Kim, Hee-Jung, Son, Byung-Ho, Ahn, Sei-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148533/
https://www.ncbi.nlm.nih.gov/pubmed/21847409
http://dx.doi.org/10.4048/jbc.2011.14.2.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148533/
https://www.ncbi.nlm.nih.gov/pubmed/21847409
http://dx.doi.org/10.4048/jbc.2011.14.2.135

Ejemplares similares